Literature DB >> 15677434

Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics.

Hong Liu-Seifert1, Bruce J Kinon, Jonna Ahl, Shaw Lamberson.   

Abstract

The aim of this study was to determine the prevalence of osteopenia in schizophrenic patients with hyperprolactinemia and to identify factors influencing bone density. Our results indicate that low bone mineral density was highly prevalent in a chronic psychiatric population treated with prolactin-elevating antipsychotics. Identified risk factors appear to be age and hyperprolactinemia for both females and males.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15677434     DOI： 10.1196/annals.1314.044

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  7 in total

Review 1.  Osteoporosis and fracture risk in people with schizophrenia.

Authors:  Taishiro Kishimoto; Marc De Hert; Harold E Carlson; Peter Manu; Christoph U Correll
Journal:  Curr Opin Psychiatry       Date:  2012-09       Impact factor: 4.741

2.  The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients.

Authors:  Süheyla Doğan Bulut; Serdar Bulut; Verda Tüzer; Mehmet Ak; Emine Ak; Cebrail Kisa; Çiğdem Aydemir; Erol Göka
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

Review 3.  Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation.

Authors:  Uriel Halbreich
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Effect of age and disease on bone mass in Japanese patients with schizophrenia.

Authors:  Norio Sugawara; Norio Yasui-Furukori; Takashi Umeda; Shoko Tsuchimine; Akira Fujii; Yasushi Sato; Manabu Saito; Hanako Furukori; Kazuma Danjo; Masashi Matsuzaka; Ippei Takahashi; Sunao Kaneko
Journal:  Ann Gen Psychiatry       Date:  2012-02-20       Impact factor: 3.455

Review 5.  Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences.

Authors:  Chien-Yu Chen; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-08-31       Impact factor: 2.582

6.  Bone mass in schizophrenia and normal populations across different decades of life.

Authors:  Jenn-Huei Renn; Nan-Ping Yang; Ching-Mo Chueh; Chih-Yuan Lin; Tsuo-Hung Lan; Pesus Chou
Journal:  BMC Musculoskelet Disord       Date:  2009-01-01       Impact factor: 2.362

7.  Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine.

Authors:  Tatjana Nikolić; Milan Petronijević; Jelena Sopta; Milica Velimirović; Tihomir Stojković; Gordana Jevtić Dožudić; Milan Aksić; Nevena V Radonjić; Nataša Petronijević
Journal:  BMC Pharmacol Toxicol       Date:  2017-10-11       Impact factor: 2.483
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.